Question 1

What is Ethionamide?

Accepted Answer

Ethionamide is a Other.

Question 2

How often does Ethionamide appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 7 articles.

Question 3

When was Ethionamide first tracked by Ergen?

Accepted Answer

First tracked on Apr 13, 2026.

Question 4

When was Ethionamide last mentioned in news?

Accepted Answer

Last active on Apr 13, 2026.

Question 5

What is Ethionamide's current news sentiment?

Accepted Answer

Aggregate sentiment score: 40 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Ethionamide in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Ethionamide?

Accepted Answer

AlpE Tuberculosis Drug Data Published (Apr 13, 2026, 7 articles).

Question 8

How did the "AlpE Tuberculosis Drug Data Published" event impact Ethionamide?

Accepted Answer

Ethionamide is an existing antibiotic whose activity is potentiated by Alphabet Inc., making it more effective against drug-resistant Mycobacterium tuberculosis strains.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.